QUOTED. 16 May 2019. Jan Welch.
The US FDA's Office of Regulatory Affairs (ORA) is grappling with a shortage of investigators, while at the same time investing in new supervisors so they're adequately prepared for when older ones retire. See what FDA's Jan Welch said about it here.
"We're sitting on a lot of vacancies right now. And that's not just in OMDRHO – that's across all of ORA." – Jan Welch, director, Office of Medical Device and Radiological Health Operations (OMDRHO)
- Find out more: Help Wanted: FDA's Office Of Regulatory Affairs Looks To Plug Investigator Vacancies, Begins 'Succession Planning'
Click here for a free trial of Medtech Insight